Medico Intercontinental Profit & Loss Annual

Trade
BSE: 539938 | NSE: - | ISIN: INE858Q01019 | Sector: Biotechnology & Drugs
59.17 +2.81 (4.99%)Updated : 26 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 71.3676.2374.2669.74
Total Revenue 71.3676.2374.2669.74
Costof Revenue Total 54.8662.3060.8457.62
Gross Profit 16.4913.9213.4212.12
Selling/ General/ Admin Expenses Total 3.923.222.312.17
Depreciation/ Amortization 0.290.200.210.14
Other Operating Expenses Total 6.364.935.805.00
Total Operating Expense 65.4270.6669.1664.93
Operating Income 5.935.565.104.81
Interest Inc( Exp) Net- Non- Op Total -4.93-6.19-8.74-12.80
Net Income Before Taxes 5.444.944.233.53
Provisionfor Income Taxes 1.491.341.130.96
Net Income After Taxes 3.953.613.102.58
Net Income Before Extra Items 3.953.613.102.58
Net Income 3.953.613.102.58
Income Availableto Com Excl Extra Ord 3.953.613.102.58
Income Availableto Com Incl Extra Ord 3.953.613.102.58
Diluted Net Income 3.953.613.102.58
Diluted Weighted Average Shares 1.000.640.320.32
Diluted EPS Excluding Extra Ord Items 3.955.619.547.93
Diluted Normalized EPS 3.955.619.547.93
Total Adjustmentsto Net Income -0.000.00-
DPS- Common Stock Primary Issue -0.10--
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,504.70+44.10(1.79%)
1,921.85+32.70(1.73%)
589.05+6.30(1.08%)
11,105.00-351.85 (-3.07%)
HomeMarketsPremiumInstant LoanMint Shorts